Legal Representation
Attorney
ROBERT S. BRODER
USPTO Deadlines
Next Deadline
1152 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-09-04)
Due Date
September 04, 2028
Grace Period Ends
March 04, 2029
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 24, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Jan 24, 2025 | C75P | O | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Jan 13, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Jun 24, 2024 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED |
| May 27, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| May 14, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Apr 1, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Oct 27, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Jul 17, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Nov 2, 2018 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Oct 15, 2018 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Oct 15, 2018 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Oct 4, 2018 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Sep 4, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 19, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 30, 2018 | NPUB | O | NOTICE OF PUBLICATION |
| May 22, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| May 19, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| May 17, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 15, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 15, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| May 10, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Chemicals derived from botanical extracts, namely, bergamot extracts, for use in the manufacture of pharmaceutical products, cosmetic products, nutritional supplements and foodsuffs
Class 005
Pharmaceutical products containing extracts from medicinal plants, namely, bergamot extracts, for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases; plant and herb extracts for medicinal and pharmaceutical use
Classification
International Classes
001
005